Previous 10 | Next 10 |
2024-05-01 09:00:05 ET Summary Shares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug. Canopy Growth Corporation saw the biggest increase, with CGC stock closing up 78.9%. However, Canopy Growth faces financ...
2024-05-01 08:51:46 ET The White House Office of Management and Budget's review of the DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could scuttle the reform, according to one assessment.... Read the full article on Seeking Alpha ...
2024-04-30 16:25:18 ET Summary The U.S. Drug Enforcement Administration (DEA) is moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, and pending approval from the White House Office of Management and Budget. Rescheduling cannabis would allow U.S. ...
2024-04-30 14:20:00 ET Summary The DEA will reportedly reclassify cannabis as a less dangerous drug, potentially moving it from Schedule I to Schedule III. Cannabis stocks surged after the news, with companies like Tilray, Canopy Growth, and Aurora Cannabis seeing a 20% increase. ...
2024-04-30 14:15:33 ET More on cannabis ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' DEA to resche...
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products Canada NewsWire NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients EDMO...
2024-04-29 10:47:03 ET Telefonaktiebolaget L M Ericsson (ERIC) ERIC is trading DOWN for the last 4 days, and it at trading at $5.16 with volume of 7,064,131 and a one day change of $-0.03 (-0.48%). Telefonaktiebolaget L M Ericsson has a 52-week low of 4.33 and a 52-week high of $6.3...
2024-04-29 08:10:00 ET The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities. When that happens, it's worth it to buy the dip. Other times, some corporations lag the market fo...
2024-04-27 17:49:49 ET Ahead of the Curve: Leading Canadian Cannabis Stocks for Early 2024 The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growt...
2024-04-24 09:30:00 ET Summary Aurora Cannabis has seen growth in international medical cannabis sales, particularly in Germany and Australia. The company has shifted its focus to the medical cannabis business, which has higher margins but limited growth opportunities. ACB sto...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- When it comes to investing in the legal marijuana industry, they don't call it the "green rush" for nothing. Many analysts are projecting massive growth for the cannabis industry. New Frontier, a Washington D.C.-based cannabis research firm, expects total U.S. legal cannabis s...
2024-07-18 05:30:00 ET To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell of its former self. Instead of acquiring large cannabis compani...
The marijuana industry has been significantly hindered by Section 280E of the IRS Code , which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses. Although Section 280E affects federal deductio...